Jacobus, S., Rajkumar, S., Weiss, M.et al.Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen.Blood Cancer Journal6, e448...
Multiple myelomaLenalidomidePegylated liposomal doxorubicinThe prognosis of multiple extramedullary plasmacytomas (MEP) and plasma cell leukemia (PCL) is extremely poor, with the median overall survival (OS) of only 8months with standard chemotherapy. Innovative treatment approaches incorporating various ...
FDA seeking approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimen for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma. News release. January 30, 2024. Accessed January 31, 2024. https://www.prnewswire.com/news-rele...
Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single c... U Hegenbart,T Bochtler,A Benner,... - 《Haematologica...